comparemela.com
Home
Live Updates
Keymed and Lepu Biopharma Jointly Announce Global Exclusive
Keymed and Lepu Biopharma Jointly Announce Global Exclusive
Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901
/PRNewswire/ -- Keymed Biosciences Inc., ("Keymed") (Stock Code: 02162 HK) and Lepu Biopharma Co., Ltd, (Stock Code: 02157.HK) today jointly announce a global...
Related Keywords
China ,
Chengdu ,
Sichuan ,
United States ,
Lepu Biopharma ,
Keymed Biosciences ,
Bo Chen ,
Keymed Biosciences Inc ,
Hong Kong Stock Exchange On ,
Lepu Biopharma Co Ltd ,
Prnewswire Keymed Biosciences Inc ,
Nasdaq ,
Biosciences Inc ,
Astrazeneca ,
Stock Code ,
Chief Executive Officer ,
Board Chairman ,
Senior Vice President ,
Biologics Engineering ,
Oncology Targeted Delivery ,
Hong Kong Stock Exchange ,
Keymed ,